On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model designed to make Most Favored Nation (MFN)-level prices available to state Medicaid programs ...
Under the model, set to start next year, the CMS will negotiate lower prices for Medicaid programs linked to those paid in select other countries with participating pharmaceutical manufacturers. Under ...
President Donald Trump, in signing dozens of executive orders on Monday, rescinded an effort by former President Joe Biden to lower drug costs by directing Medicare and Medicaid to test models that ...
U.S. Rep. Brittany Pettersen announced a bill that would improve Medicaid coverage for substance use disorder treatment to celebrate her mother's sobriety anniversary on Sept. 5, 2024, at the Sobriety ...
On September 30, 2025, the Centers for Medicare & Medicaid Services (CMS) issued final guidance (Final Guidance) for initial price applicability year (IPAY) 2028 of the Inflation Reduction Act (IRA) ...
While the American Society of Health-System Pharmacists largely supports CMS’ proposed policy revisions for Medicare Part D, Medicare Advantage and the program of all-inclusive care for the elderly, ...